$3 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 120 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVLS | New | NIVALIS THERAPEUTICS INC | $56,546,000 | – | 3,732,412 | +100.0% | 1.88% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $38,179,000 | – | 646,000 | +100.0% | 1.27% | – |
| New | SPECTRANETICS CORPmtnf 2.625% 6/0 | $37,991,000 | – | 36,901,000 | +100.0% | 1.27% | – | |
| GLPG | New | GALAPAGOS NVspon adr | $33,094,000 | – | 642,608 | +100.0% | 1.10% | – |
| GHDX | New | GENOMIC HEALTH INC | $32,876,000 | – | 1,183,000 | +100.0% | 1.10% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $30,174,000 | – | 211,850 | +100.0% | 1.00% | – |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $29,955,000 | – | 1,016,453 | +100.0% | 1.00% | – |
| HWAY | New | HEALTHWAYS INC | $29,531,000 | – | 2,465,042 | +100.0% | 0.98% | – |
| GI | New | ENDOCHOICE HLDGS INC | $29,393,000 | – | 1,797,709 | +100.0% | 0.98% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $24,875,000 | – | 1,405,348 | +100.0% | 0.83% | – |
| KMPH | New | KEMPHARM INC | $19,921,000 | – | 1,084,443 | +100.0% | 0.66% | – |
| AKRXQ | New | AKORN INC | $15,048,000 | – | 344,667 | +100.0% | 0.50% | – |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $14,993,000 | – | 212,000 | +100.0% | 0.50% | – |
| CATB | New | CATABASIS PHARMACEUTICALS IN | $9,012,000 | – | 738,055 | +100.0% | 0.30% | – |
| ALQA | New | ALLIQUA BIOMEDICAL INC | $8,849,000 | – | 1,679,111 | +100.0% | 0.30% | – |
| LIFE | New | ATYR PHARMA INC | $8,548,000 | – | 461,530 | +100.0% | 0.28% | – |
| RLYP | New | RELYPSA INC | $7,445,000 | – | 225,000 | +100.0% | 0.25% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $5,359,000 | – | 690,538 | +100.0% | 0.18% | – |
| TRIB | New | TRINITY BIOTECH PLCspon adr new | $4,741,000 | – | 262,492 | +100.0% | 0.16% | – |
| BITI | New | BIOTIE THERAPIES OYJsponsored adr | $4,385,000 | – | 219,558 | +100.0% | 0.15% | – |
| VCYT | New | VERACYTE INC | $4,269,000 | – | 383,256 | +100.0% | 0.14% | – |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $4,006,000 | – | 59,468 | +100.0% | 0.13% | – |
| CDTX | New | CIDARA THERAPEUTICS INC | $3,331,000 | – | 237,583 | +100.0% | 0.11% | – |
| IVTY | New | INVUITY INC | $3,086,000 | – | 218,523 | +100.0% | 0.10% | – |
| KND | New | KINDRED HEALTHCARE INC | $1,423,000 | – | 70,114 | +100.0% | 0.05% | – |
| TRXC | New | TRANSENTERIX INC | $884,000 | – | 294,669 | +100.0% | 0.03% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $768,000 | – | 63,700 | +100.0% | 0.03% | – |
| PRGO | New | PERRIGO CO PLC | $647,000 | – | 3,500 | +100.0% | 0.02% | – |
| POZN | New | POZEN INC | $460,000 | – | 44,583 | +100.0% | 0.02% | – |
| RCPT | New | RECEPTOS INC | $380,000 | – | 2,000 | +100.0% | 0.01% | – |
| PSDV | New | PSIVIDA CORP | $388,000 | – | 102,823 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.